Arkolith/Insider Trading/GLSI/Form 4

Patel Snehal

CEO and CFO, Director, 10% OwnerGreenwich LifeSciences, Inc. (GLSI) · full profile →Form 4 · filed Jun 27, 2022
Net Buying
Open-Market Buys
$265K
Open-Market Sells
$0
Net Open-Market Flow
$265K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2022Buy(P)23K$9.13$206K2.7M
Jun 24, 2022Buy(P)6K$9.13$59K2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-017786) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML